Book Closure

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE5271.1053.25 (+1.02 %)
PREV CLOSE ( ) 5217.85
OPEN PRICE ( ) 5284.75
BID PRICE (QTY) 5262.80 (2)
OFFER PRICE (QTY) 5279.15 (1)
VOLUME 530
TODAY'S LOW / HIGH ( )5154.50 5287.75
52 WK LOW / HIGH ( )3118.55 7208
NSE5290.0046.1 (+0.88 %)
PREV CLOSE( ) 5243.90
OPEN PRICE ( ) 5239.90
BID PRICE (QTY) 5281.25 (1)
OFFER PRICE (QTY) 5289.00 (2)
VOLUME 2030
TODAY'S LOW / HIGH( ) 5202.95 5290.00
52 WK LOW / HIGH ( )3098 7220.95

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.